Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer
Pancreatic cancer (PanCa) is projected to become the second major cause of cancer-related mortality by 2030. The current diagnostic and treatment strategies offer only marginal benefits in overall survival. This highlights the need to discover new biomarkers and targets for the treatment of PanCa. D...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-08-01
|
| Seri Bilgileri: | Translational Oncology |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1936523325001639 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|